{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:56:27Z","timestamp":1792814187297,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["\u2019PRIN\u2019 2017, project 2017728JPK"],"award-info":[{"award-number":["\u2019PRIN\u2019 2017, project 2017728JPK"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pregnancy associated cancer (PAC) may lead to adverse obstetric and neonatal outcomes. This study aims to assess the association between PACs and adverse perinatal outcomes [i.e. labor induction, iatrogenic delivery, preterm birth, small for gestational age (SGA) newborn, low Apgar score, major malformations, perinatal mortality] in Lombardy, Northern Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based historic cohort study used the certificate of delivery assistance and the regional healthcare utilization databases of Lombardy Region to identify beneficiaries of National Health Service who delivered between 2008 and 2017. PACs were defined through oncological ICD-9-CM codes reported in the hospital discharge forms. Each woman with PAC was matched to four women randomly selected from those cancer-free (1:4). Log-binomial regression models were fitted to estimate crude and adjusted prevalence ratio (aPR) and the corresponding 95% confidence interval (CI) of each perinatal outcome among PAC and cancer-free women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of the 657,968 deliveries, 831 PACs were identified (1.26 per 1000). PAC diagnosed during pregnancy was positively associated with labor induction or planned delivery (aPR=1.80, 95% CI: 1.57\u20132.07), cesarean section (aPR=1.78, 95% CI: 1.49\u20132.11) and premature birth (aPR=6.34, 95% CI: 4.59\u20138.75). No association with obstetric outcomes was found among PAC diagnosed in the post-pregnancy. No association of PAC, neither during pregnancy nor in post-pregnancy was found for SGA (aPR=0.71, 95% CI: 0.36\u20131.35 and aPR=1.04, 95% CI: 0.78\u20131.39, respectively), but newborn among PAC women had a lower birth weight (\n                      <jats:italic>p<\/jats:italic>\n                      -value&lt;\u20090.001). Newborns of women with PAC diagnosed during pregnancy had a higher risk of borderline significance of a low Apgar score (aPR=2.65, 95% CI: 0.96\u20137.33) as compared to cancer-free women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PAC, especially when diagnosed during pregnancy, is associated with iatrogenic preterm delivery, compromising some neonatal heath indicators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-020-03508-4","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T12:03:50Z","timestamp":1610021030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Obstetric and neonatal outcomes in women with pregnancy associated cancer: a population-based study in Lombardy, Northern Italy"],"prefix":"10.1186","volume":"21","author":[{"given":"Giovanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Dalmartello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-4854","authenticated-orcid":false,"given":"Fabio","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3508_CR1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1067\/mob.2001.114867","volume":"184","author":"LH Smith","year":"2001","unstructured":"Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184:1504\u201312.","journal-title":"Am J Obstet Gynecol"},{"key":"3508_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1067\/S0002-9378(03)00537-4","volume":"189","author":"LH Smith","year":"2003","unstructured":"Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189:1128\u201335.","journal-title":"Am J Obstet Gynecol"},{"key":"3508_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14767050500123962","volume":"17","author":"JL Dalrymple","year":"2005","unstructured":"Dalrymple JL, Gilbert WM, Leiserowitz GS, Cress R, Xing G, Danielsen B, et al. Pregnancy-associated cervical cancer: obstetric outcomes. J Matern Fetal Neonatal Med. 2005;17:269\u201376.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3508_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/AOG.0b013e3181b19154","volume":"114","author":"TM Andersson","year":"2009","unstructured":"Andersson TM, Johansson AL, Hsieh CC, Cnattingius S, Lambe M. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114:568\u201372.","journal-title":"Obstet Gynecol"},{"key":"3508_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/14767050802559111","volume":"22","author":"MT Dahling","year":"2009","unstructured":"Dahling MT, Xing G, Cress R, Danielsen B, Smith LH. Pregnancy associated colon and rectal cancer: perinatal and cancer outcomes. J Matern Fetal Neonatal Med. 2009;22:204\u201311.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"3508_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/cancers12061356","volume":"12","author":"M Dalmartello","year":"2020","unstructured":"Dalmartello M, Negri E, La Vecchia C, Scarfone G, Buonomo B, Peccatori FA, Parazzini F. Frequency of pregnancy-associated Cancer: a systematic review of population-based studies. Cancers. 2020;12(6):1356.","journal-title":"Cancers"},{"issue":"1","key":"3508_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajog.2013.12.002","volume":"211","author":"R Salani","year":"2014","unstructured":"Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstetr Gynecol Jul. 2014;211(1):7\u201314.","journal-title":"Am J Obstetr Gynecol Jul."},{"key":"3508_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28:683\u20139.","journal-title":"J Clin Oncol"},{"key":"3508_CR9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1471-0528.2012.03475.x","volume":"119","author":"YY Lee","year":"2012","unstructured":"Lee YY, Roberts CL, Dobbins T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. BJOG. 2012;119:1572\u201382.","journal-title":"BJOG."},{"issue":"4","key":"3508_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/00016347009157259","volume":"49","author":"U Nieminen","year":"1970","unstructured":"Nieminen U, Remes N. Malignancy during pregnancy. Acta Obstet Gynecol Scand. 1970;49(4):315\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"3508_CR11","first-page":"1005","volume":"2","author":"E Cardonick","year":"2019","unstructured":"Cardonick E, Eicheldinger E, Gaughan JP. Chemotherapy is avoided during the first trimester of pregnancy, when is the safest time to start treatment during the second or third trimester? ProClinS Gynecology and Obstetrics. 2019;2(1):1005.","journal-title":"ProClinS Gynecology and Obstetrics"},{"issue":"7","key":"3508_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12325-018-0735-8","volume":"35","author":"A Cantarutti","year":"2018","unstructured":"Cantarutti A, Franchi M, Rea F, Merlino L, Corrao G. Use of Nimesulide during early pregnancy and the risk of congenital malformations: a population-based study from Italy. Adv Ther. 2018;35(7):981\u201392.","journal-title":"Adv Ther"},{"issue":"Suppl 1","key":"3508_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2393-10-S1-S1","volume":"10","author":"JE Lawn","year":"2010","unstructured":"Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C, GAPPS Review Group. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10(Suppl 1):S1.","journal-title":"BMC Pregnancy Childbirth"},{"key":"3508_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJM200102153440701","volume":"344","author":"BM Casey","year":"2001","unstructured":"Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med. 2001;344:467\u201371.","journal-title":"N Engl J Med"},{"key":"3508_CR15","first-page":"93","volume":"20","author":"F Parazzini","year":"1998","unstructured":"Parazzini F, Cortinovis I, Bortolus R, Zanardo V. Weight at birth between 23a and 42a weeks of gestation in Italy. Med Surg Ped. 1998;20:93\u20137.","journal-title":"Med Surg Ped"},{"issue":"3","key":"3508_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"3508_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121\u201330 PubMed PMID: 3719049.","journal-title":"Biometrics."},{"issue":"1","key":"3508_CR18","doi-asserted-by":"publisher","first-page":"e0116362","DOI":"10.1371\/journal.pone.0116362","volume":"10","author":"MC Magnus","year":"2015","unstructured":"Magnus MC, Stigum H, H\u00e5berg SE, Nafstad P, London SJ, Nystad W. Peak weight and height velocity to age 36 months and asthma development: the Norwegian mother and child cohort study. PLoS One. 2015;10(1):e0116362.","journal-title":"PLoS One"},{"issue":"2","key":"3508_CR19","doi-asserted-by":"publisher","first-page":"e0117512","DOI":"10.1371\/journal.pone.0117512","volume":"10","author":"J Verret-Chalifour","year":"2015","unstructured":"Verret-Chalifour J, Gigu\u00e8re Y, Forest JC, Croteau J, Zhang P, Marc I. Breastfeeding initiation: impact of obesity in a large Canadian perinatal cohort study. PLoS One. 2015;10(2):e0117512.","journal-title":"PLoS One"},{"issue":"12","key":"3508_CR20","doi-asserted-by":"publisher","first-page":"e022946","DOI":"10.1136\/bmjopen-2018-022946","volume":"8","author":"NC Momen","year":"2018","unstructured":"Momen NC, Arendt LH, Ernst A, Olsen J, Li J, Gissler M, Ramlau-Hansen CH. Pregnancy-associated cancers and birth outcomes in children: A Danish and Swedish population-based register study. BMJ Open. 2018;8(12):e022946.","journal-title":"BMJ Open."},{"issue":"1","key":"3508_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/jpm-2016-0212","volume":"46","author":"K Jeremic","year":"2018","unstructured":"Jeremic K, Stefanovic A, Dotlic J, Kadija S, Kontic O, Gojnic M, Jeremic J, Kesic V. Cancer during pregnancy clinical characteristics, treatment outcomes and prognosis for mothers and infants. J Perinat Med. 2018;46(1):35\u201345.","journal-title":"J Perinat Med"},{"key":"3508_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","volume":"19","author":"J de Hann","year":"2018","unstructured":"de Hann J, Verheecke M, Van Calsteren K, Van Caalster B, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20 year international cohort study of 1170 patients. Lancet Oncol. 2018;19:337\u201346.","journal-title":"Lancet Oncol"},{"key":"3508_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s10147-018-1352-x","volume":"24","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Tabata T, Omori M, Kondo E, Hirata T, Yoshida K, Sekine M, Itakura A, Enomoto T, Ikeda T. A Japanese survey of malignant disease in pregnancy. Int J Clin Oncol. 2019;24:328\u201333.","journal-title":"Int J Clin Oncol"},{"key":"3508_CR24","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1200\/JCO.2016.69.9439","volume":"35","author":"L Donghao","year":"2017","unstructured":"Donghao L, Ludvigsson JF, Smedby KE, Fall K, Valdimarsdottir U, Cnattingius S, Fang F. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. J Clin Oncol. 2017;35:1522\u20139.","journal-title":"J Clin Oncol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03508-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-03508-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03508-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T14:13:16Z","timestamp":1610287996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03508-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3508"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03508-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-67757\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Ethics approval section could you please provide a reference that explicitly states that ethics approval is not needed? Alternatively, please indicate if the need for ethical approval has been waived by an IRB.The Ethical Committee of the University of Milano-Bicocca eval-.uated the protocol and established that the study (a) was.exempt from informed consent (according to General.This analysis is exempt from IRB authorization and informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes issued by the Italian Privacy Authority on December 15, 2016;\n                      \n                      home\/docweb\/\u2212\/docweb-display\/docweb\/5805552),Data and permission for the analysis were obtained by the Regional Health Authorities of Lombardy, Italy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drugs (AIFA), and the Italian Ministry for University and Research (MIUR). He took part in a variety of projects that were funded by pharmaceutical companies (i.e. Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as a member of the advisory board to Roche. The other authors declare that they have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}